Saturday, June 20, 2026

A 5-Year Enrollment Surge Meets Regional Care Gaps: Can a New Medical School Open Before 2030?

The Korean government plans to increase medical school enrollment and establish new schools in underserved regions by 2030.

Former Defense Chief Reveals US Military Supply Chain Vulnerabilities During 2017 North Korea Crisis

Mark Esper reflects on U.S. defense vulnerabilities and the need for strong leadership to prepare for prolonged conflicts, especially with North Korea.

AITRICS to Showcase AI Clinical Solutions at KIMES 2026

AITRICS will showcase its clinical AI solutions at KIMES 2026, enhancing healthcare efficiency and patient safety with innovative technologies.

Tag: Daewoong Pharmaceutical

North KoreaKoreaKimMilitaryAISouth KoreamarketrelationsInternational

Daewoong Pharmaceutical Expands Biosimilar Push With Dupixent Copy Deal and Global CDMO Partnership

Daewoong Pharmaceutical partners with Chime Biologics to develop a Dupixent biosimilar, enhancing its global biosimilar business expansion.

Daewoong Pharmaceutical Partners With Seers and TR to Develop Integrated Smart Ward Respiratory Care Solution

Daewoong Pharmaceutical signed an MOU with Cears and TR for the expansion of digital healthcare solutions.

Daewoong Pharmaceutical Gains Mexico Approval for Type 2 Diabetes Drug as Latin America Expansion Accelerates

Daewoong Pharmaceutical's type 2 diabetes drug Enblo has received approval in Mexico, a key market in Latin America.

Daewoong Pharmaceutical Completes Global Phase 2 Trials for First-in-Class IPF Treatment

Daewoong Pharmaceutical completes patient recruitment for a Phase 2 trial of Bersiporocin, a potential treatment for idiopathic pulmonary fibrosis.

Daewoong Pharmaceutical and Primind’s Strategic Investment in American Biotech General Proximity

Daewoong Pharmaceutical invests in biotech firms to enhance drug development using Induced Proximity technology and expand globally.

Daewoong Pharmaceutical and Puzzle AI to Supply AI Medical Record Solution CL Note

Daewoong Pharmaceutical partners with Puzzle AI to enhance digital healthcare with CL Note, streamlining hospital operations and patient care.

Fexuclue 40mg: How This New GERD Treatment is Revolutionizing Healthcare in Indonesia

Daewoong Pharmaceutical's Fexuclue receives approval in Indonesia for treating GERD, aiming for rapid expansion in the market.

Daewoong Pharmaceutical holds “Nabota Master Class,” demonstrates proprietary procedures

Daewoong Pharmaceutical hosted the "Nabota Master Class" for 74 medical professionals from 13 countries, focusing on safety and clinical application.

Daewoong Pharmaceutical Expands Indication for Fexuclue: What This Means for 2026

Daewoong Pharmaceutical submits Phase 3 trial plan for Fexuclue to treat gastric ulcers, aiming to enhance treatment options and patient quality of life.

2026 Digital Healthcare Revolution: How Daewoong Pharmaceutical and Puzzle AI are Automating Medical Records

Daewoong Pharmaceutical's Innovare Partners Day showcased AI in healthcare, featuring voice-based EMR and innovations in brain health.

Daewoong’s Hub System Aims to End Drug Shortages With Predictive Data

Daewoong Pharmaceutical is enhancing drug distribution with a data-driven hub system for better inventory management and transparency.

Discover the Breakthrough: Daewoong’s CleanCol Tablet Reduces Dosage for Effective Colon Cleansing

Daewoong Pharmaceutical's Cleancol Tab. shows effective bowel cleansing with fewer tablets, improving patient adherence during colonoscopy prep.

CM Hospital’s thynC System: The Future of Patient Monitoring and Safety in Healthcare

Daewoong Pharmaceutical launches thynC, an AI-powered monitoring system at CM Hospital to enhance patient safety and healthcare quality.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.